Big Call Scan: Vinci, Sanofi, RTX, SAP

Defensive stocks are increasingly coming into focus given the escalating trade dispute between the USA and China. Among the favorites is the French pharmaceutical company Sanofi, especially since it boasts excellent prospects thanks to its two blockbuster drugs, Dupixient and Beyfortus, as well as a promising pipeline. Fundamentally, Sanofi also impresses with its attractive valuation, making it a favorite in the pharmaceutical sector on the selection list at "The Big Call." Currently, Vinci's price action is very bullish. The French conglomerate,...